Top 10 Indian Pharmaceutical Manufacturers Of Antitumor Drugs

As India's largest pharmaceutical company and the world's fourth-largest generic drug company, Sun Pharma covers multiple fields including oncology. It has a prominent performance in the production and sales of chronic and acute therapeutic drugs, including APIs, generic drugs, and various anti-tumor medications.

As a major producer of oncology/anti-cancer APIs in India, Dr. Reddy's owns an experienced team and provides key ingredients such as kinase inhibitors, androgen receptor inhibitors, and microtubule inhibitors. Its facilities comply with GMP regulations, ensuring the quality of anti-cancer drugs through the QBD (Quality by Design) process.

A global leader in the pharmaceutical industry and a top player in India's pharmaceutical sector, Cipla has optimized a diversified oncology product portfolio, including 32 different targeted formulations. It can complete everything from API production to extensive clinical research in-house.

Renowned for its multi-faceted production capabilities, Lupin's therapeutic areas include oncology. Its oncology production facility in Indore focuses on developing high-potency drugs, with over 15 manufacturing bases worldwide that meet international regulatory standards.

Specializing in lyophilized formulations (a key process for stabilizing sensitive cancer therapies in anti-tumor drugs), Aurobindo adopts a vertically integrated model-from synthesizing APIs to formulating dosage forms-to ensure quality throughout the supply chain. It owns a diverse oncology product portfolio, including next-generation kinase inhibitors and immunooncology drugs.

Torrent Pharmaceuticals offers both generic and patented formulations, including treatments for blood cancers and solid tumors. Headquartered in Ahmedabad, Gujarat, it operates in over 40 countries with more than 2,000 registered products globally.

Focused on developing and producing cost-effective anti-tumor drugs, Natco covers therapeutic areas such as liver cancer, breast cancer, and blood cancer. It is renowned for manufacturing targeted drugs like osimertinib and afatinib.

As a leading manufacturer of oncology APIs and finished formulations, Hetero Healthcare provides a wide range of anti-cancer drugs globally.

Dedicated to building a global presence in fields like oncology, Glenmark's Ichnos Glenmark Innovation focuses on R&D for anti-tumor drugs. It owns innovative oncology molecules in clinical stages for multiple myeloma, acute myeloid leukemia, and solid tumors.

One of India's top oncology pharmaceutical companies, Pinnacle Life Science produces various oncology drugs within specific dosage ranges. Its GMP-certified facilities manufacture over 3 billion tablets and 300 million capsules annually, making it a leading exporter to more than 90 countries.